trial

Mindfulness RCT for Early Psychosis

NCTId NCT02244970
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 60 (estimated)
Sponsored by The University of Hong Kong
Primary completion 2015-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-09
Primary completion
2015-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
MindfulnessPsychoeducation

Sponsors

The University of Hong KongLead Sponsor

Investigators

1
JingXia Lin, PhDPrincipal Investigator

Sites

1 total
Hong Kong, China

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2015-09
Status
UNKNOWN
relationships
The graph out of here
drug
Mindfulness
drug
Psychoeducation
drug
lead_sponsor
The University of Hong Kong
company
indication
Psychosis
indication
Anxiety Disorders
indication
Psychotic Disorders
indication
investigator
JingXia Lin, PhD
person